TNFRSF13C

TNF receptor superfamily member 13C, the group of CD molecules|Tumor necrosis factor receptor superfamily

Basic information

Region (hg38): 22:41922032-41926806

Links

ENSG00000159958NCBI:115650OMIM:606269HGNC:17755Uniprot:Q96RJ3AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • common variable immunodeficiency (Supportive), mode of inheritance: AD
  • immunodeficiency, common variable, 4 (Limited), mode of inheritance: Unknown
  • immunodeficiency, common variable, 4 (Limited), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Immunodeficiency, common variable 4ARAllergy/Immunology/InfectiousIndividuals may be susceptible to a number of infections, and antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficialAllergy/Immunology/Infectious19666484
Although the condition has only been described in adults, interventions may be indicated in the pediatric period

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TNFRSF13C gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNFRSF13C gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
41
clinvar
1
clinvar
44
missense
1
clinvar
65
clinvar
1
clinvar
67
nonsense
0
start loss
1
clinvar
1
frameshift
1
clinvar
1
inframe indel
8
clinvar
8
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
2
2
non coding
5
clinvar
9
clinvar
6
clinvar
20
Total 0 1 83 50 8

Variants in TNFRSF13C

This is a list of pathogenic ClinVar variants found in the TNFRSF13C region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
22-41925114-G-A Immunodeficiency, common variable, 4 Uncertain significance (Jan 12, 2018)902821
22-41925247-A-G Immunodeficiency, common variable, 4 Benign (Jun 19, 2021)341874
22-41925254-C-T Immunodeficiency, common variable, 4 Uncertain significance (Jan 13, 2018)341875
22-41925260-C-G Immunodeficiency, common variable, 4 Uncertain significance (Jan 13, 2018)902822
22-41925357-C-G TNFRSF13C-related disorder Likely benign (May 08, 2019)3042050
22-41925379-AGGGCCGGCC-CCTGCTATT Immunodeficiency, common variable, 4 Uncertain significance (Dec 11, 2023)660119
22-41925384-C-G Immunodeficiency, common variable, 4 Uncertain significance (May 22, 2023)3015715
22-41925384-C-T Immunodeficiency, common variable, 4 Uncertain significance (Dec 22, 2022)1063719
22-41925385-G-A Immunodeficiency, common variable, 4 Likely benign (Aug 30, 2022)1602464
22-41925385-G-C Immunodeficiency, common variable, 4 Likely benign (Sep 01, 2022)1655369
22-41925400-C-T Immunodeficiency, common variable, 4 Likely benign (May 09, 2022)2128839
22-41925410-G-C Immunodeficiency, common variable, 4 • not specified Uncertain significance (Jan 24, 2024)2000549
22-41925411-T-A Immunodeficiency, common variable, 4 Uncertain significance (Feb 27, 2023)1931287
22-41925414-A-G Immunodeficiency, common variable, 4 Uncertain significance (Dec 19, 2023)3000794
22-41925415-G-A Immunodeficiency, common variable, 4 Likely benign (Feb 04, 2020)1142814
22-41925418-C-T Immunodeficiency, common variable, 4 Likely benign (Jun 15, 2023)2146176
22-41925425-G-A Immunodeficiency, common variable, 4 Uncertain significance (Jun 22, 2021)1470403
22-41925437-G-A Immunodeficiency, common variable, 4 Uncertain significance (Aug 08, 2018)659163
22-41925443-C-A Immunodeficiency, common variable, 4 Uncertain significance (Aug 31, 2021)1439329
22-41925444-T-C Immunodeficiency, common variable, 4 Uncertain significance (Jun 21, 2019)575709
22-41925447-G-A Immunodeficiency, common variable, 4 Conflicting classifications of pathogenicity (Aug 01, 2024)440345
22-41925470-T-A Immunodeficiency, common variable, 4 Uncertain significance (Jun 20, 2022)1490092
22-41925475-C-T Immunodeficiency, common variable, 4 Likely benign (Dec 10, 2023)753876
22-41925477-C-T Immunodeficiency, common variable, 4 Uncertain significance (Dec 26, 2023)2072872
22-41925486-G-A Immunodeficiency, common variable, 4 Conflicting classifications of pathogenicity (Jan 25, 2024)717071

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TNFRSF13Cprotein_codingprotein_codingENST00000291232 31778
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.2700.644125149011251500.00000400
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6456581.40.7990.000003941101
Missense in Polyphen1523.160.64768316
Synonymous-2.135941.51.420.00000215459
Loss of Function1.2813.640.2751.56e-747

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000008840.00000884
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: B-cell receptor specific for TNFSF13B/TALL1/BAFF/BLyS. Promotes the survival of mature B-cells and the B-cell response. {ECO:0000269|PubMed:11591325, ECO:0000269|PubMed:12387744}.;
Pathway
Primary immunodeficiency - Homo sapiens (human);HTLV-I infection - Homo sapiens (human);NF-kappa B signaling pathway - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);Intestinal immune network for IgA production - Homo sapiens (human);TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway;TNFR2 non-canonical NF-kB pathway;Cytokine Signaling in Immune system;Immune System (Consensus)

Recessive Scores

pRec
0.177

Haploinsufficiency Scores

pHI
0.0982
hipred
N
hipred_score
0.353
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.777

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tnfrsf13c
Phenotype
homeostasis/metabolism phenotype; immune system phenotype; hematopoietic system phenotype;

Gene ontology

Biological process
B cell homeostasis;adaptive immune response;positive regulation of germinal center formation;positive regulation of B cell proliferation;T cell costimulation;B cell costimulation;tumor necrosis factor-mediated signaling pathway;positive regulation of T cell proliferation;positive regulation of interferon-gamma biosynthetic process
Cellular component
plasma membrane;external side of plasma membrane;integral component of membrane
Molecular function